NASDAQ:GYRO Gyrodyne Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Gyrodyne LLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $17.20 0.00 (0.00 %) (As of 09/23/2020 12:00 AM ET) Add Compare Share Today's Range$17.20Now: $17.20▼$17.2050-Day Range$16.45MA: $17.30▼$17.7552-Week Range$14.20Now: $17.20▼$20.00VolumeN/AAverage Volume1,380 shsMarket Capitalization$25.45 millionP/E RatioN/ADividend YieldN/ABeta0.54 ProfileChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Gyrodyne, LLC. owns, leases and manages diverse commercial properties. The firm is distinguished by its service-oriented philosophy toward property ownership and management. Gyrodyne has grown from a largely Long Island player during the past into a diversified East Coast presence with an emphasis on medical office product.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Gyrodyne. Previous Next 2.5 Community Rank Outperform VotesGyrodyne has received 89 “outperform” votes. (Add your “outperform” vote.)Underperform VotesGyrodyne has received 90 “underperform” votes. (Add your “underperform” vote.)Community SentimentGyrodyne has received 50.28% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Gyrodyne and other stocks. Vote “Outperform” if you believe GYRO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe GYRO will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldGyrodyne does not currently pay a dividend.Dividend GrowthGyrodyne does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Gyrodyne insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.10% of the stock of Gyrodyne is held by insiders.Percentage Held by InstitutionsOnly 32.51% of the stock of Gyrodyne is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Book Value per Share RatioGyrodyne has a P/B Ratio of 0.81. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.63 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Nonresidential building operators Sub-IndustryDiversified REITs SectorFinance Current SymbolNASDAQ:GYRO Previous Symbol CUSIP40382010 CIK1589061 Webwww.gyrodyne.com Phone631-584-5400Debt Debt-to-Equity Ratio0.14 Current Ratio1.69 Quick Ratio1.69Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$21.20 per share Price / Book0.81Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees6 Outstanding Shares1,480,000Market Cap$25.45 million Next Earnings DateN/A OptionableNot Optionable $17.20 0.00 (0.00 %) (As of 09/23/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive GYRO News and Ratings via Email Sign-up to receive the latest news and ratings for GYRO and its competitors with MarketBeat's FREE daily newsletter. Gyrodyne (NASDAQ:GYRO) Frequently Asked Questions How has Gyrodyne's stock been impacted by COVID-19? Gyrodyne's stock was trading at $18.5084 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, GYRO stock has decreased by 7.1% and is now trading at $17.1960. View which stocks have been most impacted by COVID-19. Who are some of Gyrodyne's key competitors? Some companies that are related to Gyrodyne include Duke Realty (DRE), Vornado Realty Trust (VNO), Cousins Properties (CUZ), Spirit Realty Capital (SRC), PS Business Parks (PSB), Lexington Realty Trust (LXP), Washington Real Estate Investment Trust (WRE), American Assets Trust (AAT), Investors Real Estate Trust Reit (IRET), Gladstone Commercial (GOOD), One Liberty Properties (OLP) and Whitestone REIT (WSR). View all competitors. What other stocks do shareholders of Gyrodyne own? Based on aggregate information from My MarketBeat watchlists, some companies that other Gyrodyne investors own include Acasti Pharma (ACST), Amyris (AMRS), Ariad Pharmaceuticals (ARIA), Astrotech (ASTC), Athersys (ATHX), Avanir Pharmaceuticals (AVNR), Bank of America (BAC), Citigroup (C), China Auto Logistics (CALI) and Chelsea Therapeutics International (CHTP). Who are Gyrodyne's key executives? Gyrodyne's management team includes the following people: Mr. Gary Jay Fitlin, Pres, CEO, CFO & Treasurer (Age 54)Mr. Peter Pitsiokos, Chief Compliance officer, COO, Exec. VP & Sec. (Age 59) What is Gyrodyne's stock symbol? Gyrodyne trades on the NASDAQ under the ticker symbol "GYRO." How do I buy shares of Gyrodyne? Shares of GYRO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Gyrodyne's stock price today? One share of GYRO stock can currently be purchased for approximately $17.20. How big of a company is Gyrodyne? Gyrodyne has a market capitalization of $25.45 million. Gyrodyne employs 6 workers across the globe. What is Gyrodyne's official website? The official website for Gyrodyne is www.gyrodyne.com. How can I contact Gyrodyne? Gyrodyne's mailing address is 1 FLOWERFIELD SUITE 24, ST. JAMES NY, 11780. The real estate investment trust can be reached via phone at 631-584-5400. This page was last updated on 9/24/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
